Kazia Therapeutics Год IPO
Что обозначает Год IPO в Kazia Therapeutics?
Год IPO Kazia Therapeutics Limited является 1994
Какое определение для Год IPO?
Первичное публичное размещение акций - это тип публичного предложения, при котором акции компании обычно продаются институциональным инвесторам, которые, в свою очередь, впервые продают эти акции широкой публике на фондовой бирже.
Through IPO a privately held company transforms into a public company. Initial public offerings are mostly used by companies to raise the expansion of capital, possibly to monetize the investments of early private investors, and to become publicly traded enterprises. A company selling shares is never required to repay the capital to its public investors. After the IPO, when shares trade freely in the open market, money passes between public investors.
Although IPO offers many advantages, there are also significant disadvantages, chief among these are the costs associated with the process and the requirement to disclose certain information that could prove helpful to competitors.
The IPO process is colloquially known as going public. Details of the proposed offering are disclosed to potential purchasers in the form of a lengthy document known as a prospectus. Most companies undertake an IPO with the assistance of an investment banking firm acting in the capacity of an underwriter. Underwriters provide several services, including help with correctly assessing the value of shares.
Год IPO компаний в Health Care сектор на ASX по сравнению с Kazia Therapeutics
Что делает Kazia Therapeutics?
Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is GDC-0084, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. The company is also developing Cantrixil, which is being developed for the treatment of ovarian cancer and is in hospitals across Australia and the United States under an Investigational New Drug application. Kazia Therapeutics Limited has collaboration agreements St Jude Childrens Hospital; Dana-Farber Cancer Institute; Alliance for Clinical Trials in Oncology; Memorial Sloan Kettering Cancer Centre; and University of Newcastle. The company was formerly known as Novogen Limited and changed its name to Kazia Therapeutics Limited in November 2017. Kazia Therapeutics Limited was founded in 1994 and is based in Sydney, Australia.
Компании с год ipo похож на Kazia Therapeutics
- Sinopec Shanghai Petrochemical Co имеет Год IPO из 1993
- Delaware Investments Minnesota Municipal Income Fund II Inc имеет Год IPO из 1993
- Delaware Investments Colorado Insured Municipal Income Fund Inc имеет Год IPO из 1993
- Western Asset Municipal Partners Fund Inc имеет Год IPO из 1993
- Nuveen Maryland Quality Municipal Income Fund имеет Год IPO из 1993
- Enel Americas SA имеет Год IPO из 1993
- Kazia Therapeutics имеет Год IPO из 1994
- Hanover Insurance Inc имеет Год IPO из 1995
- Atlanticus Corp имеет Год IPO из 1995
- Integra Lifesciences Corp имеет Год IPO из 1995
- Telkom Indonesia (Persero) Tbk PT имеет Год IPO из 1995
- Myriad Genetics имеет Год IPO из 1995
- Redwood Trust имеет Год IPO из 1995